Mehul Desai, PharmD, serves as Vice-President of Medical/Clinical Affairs at Enable Injections. His experience in medical affairs includes clinical development planning, clinical trial execution and business development at argenx, field medical assignments in rare disease, nephrology and neurology for Mallinckrodt Pharmaceuticals, nephrology and haematology for Alexion Pharmaceuticals, and post-doctoral fellowship work in medical affairs for Johnson & Johnson. Dr Desai holds a bachelor’s degree in Biochemistry and Business Foundations from Indiana University (Bloomington, IN, US); a PharmD from Purdue University (West Lafayette, IN, US); and an MBA in Pharmaceutical and Healthcare Business from the University of the Sciences (Philadelphia, PA, US).

More contributions